Season’s Greetings 2020 from DOSIsoft
- December 19, 2019
Merry Christmas & Happy New Year 2020! We thank you for all the support & trust you bring to improve cancer treatment quality and patient safety!
[AuntMinnie.com] DOSIsoft gets FDA nod for MU2net software
- November 11, 2019
Radiation oncology and nuclear medicine software developer DOSIsoft has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its MU2net software for independent secondary dose calculation for patient quality assurance.
DOSIsoft MU2net is FDA 510(k) Cleared for Patient QA – Secondary Dose Calculation
- November 7, 2019
DOSIsoft, leading provider of patient-specific software solutions for Radiation Oncology and Nuclear Medicine, is pleased to announce that on October 24th, 2019, it received 510(k) clearance from the US Food and Drug Administration (FDA), to market MU2net, software dedicated to Independent Secondary Dose Calculation for Patient Quality Assurance (QA).
MU2net Unity: 1st Product Release
- October 7, 2019
Supporting adaptive workflows, MU2net releases its first version 188.8.131.52 compatible with Elekta Unity (MLC-Y) to perform secondary independent dose calculation.
EANM ANNUAL CONGRESS 2019
- September 16, 2019
Annual Congress of the European Association of Nuclear Medicine (EANM)
October 12-16, 2019
CCIB – Centre de Convencions Internacional de Barcelona, Spain
APMP Seminar 2019
- September 10, 2019
October 12, 2019
Hôtel Mélia Paris La Défense, France
[AuntMinnie.com] Elekta, DOSIsoft sign distribution agreement
- September 6, 2019
Radiation oncology vendor Elekta has signed a distribution agreement with radiation oncology and nuclear medicine software developer DOSIsoft.
[Elekta’s PR] Elekta announces Exclusive Agreement with DOSIsoft for Distribution of Key Patient Specific QA Solutions
- September 5, 2019
Products fill out company’s Elekta Assurance portfolio for comprehensive end-to-end quality assurance.
- September 1, 2019
Annual Symposium on Clinical Interventional Oncology (CIO)
October 11-13, 2019
Eden Roc Miami Beach, Miami Beach, USA
[Article] Analysis of Differences Between 99mTc-MAASPECT- and 90Y-microsphere PET-based Dosimetry for Hepatocellular Carcinoma Selective Internal Radiation Therapy
- July 22, 2019
Marilyne Kafrouni, Carole Allimant, Marjolaine Fourcade, Sébastien Vauclin, et al.
EJNMMI Res (2019) 9: 62. https://doi.org/10.1186/s13550-019-0533-6